- Source : Press Release
- Date : 2021-08-04
- Companies : Tempus, Inc.
Tempus Announces New Genomic Sequencing Lab in Research Triangle Park in Durham, NC
Tempus, a leader in artificial intelligence and precision medicine, today announced its new, state-of-the-art genomic sequencing lab in Durham’s Research Triangle Park (RTP). The 52,000-square foot space marks Tempus’ third laboratory, joining the company’s existing CAP-accredited/CLIA-certified labs in Atlanta and its Chicago headquarters.
RTP’s proximity to three tier-1 research universities has made it a hub for innovation, attracting some of the country’s most forward-thinking companies and making it the ideal location for Tempus’ new lab. When it opens in late 2021, Tempus aims to initially hire around 200 team members to staff the high-throughput lab, which will primarily focus on Tempus’ next-generation, genomic sequencing work in oncology. The lab will run the company’s leading, broad-panel solid and liquid assays, among others, which generate high-quality somatic and germline molecular data, along with therapeutic context. These findings help empower physicians to make personalized, data-driven decisions regarding their patients’ treatment options.
“Over the last few years, we have considerably grown our diagnostic testing business in both our Chicago and Atlanta labs. As we approached our current capacity, we sought a facility in which we can build a state-of-the-art lab to support our diagnostic growth,” said Kimberly Yeatts, Vice President of Lab Operations. “The Research Triangle has historically been very supportive of health tech businesses like ours, so we are thrilled to be joining this dynamic community.”
Tempus is focused on advancing precision medicine through its proprietary data platform that ingests multi-modal data across major disease types and analyzes that data looking for therapeutically relevant insights. Tempus organizes phenotypic, morphological, and molecular data in real-time, enabling the company to add clinical context to physician-ordered laboratory tests. Tempus’ “smart” laboratory tests are available clinically, touching the lives of millions of patients in the U.S.
Tempus is a technology company advancing precision medicine through the practical application of artificial intelligence in healthcare. With one of the world’s largest libraries of clinical and molecular data, and an operating system to make that data accessible and useful, Tempus enables physicians to make real-time, data-driven decisions to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics. The goal is for each patient to benefit from the treatment of others who came before by providing physicians with tools that learn as the company gathers more data. For more information, visit tempus.com.